|
your path: Home
> News >
FOR IMMEDIATE RELEASE
May 9, 2001
American Geriatrics Society
Contact: Pamela W. Ingham
(312) 565-1234, ext. 4115
pingham@americangeriatrics.org
Chicago, IL
The war on drugs has an unintended
consequence-millions of dying patients cannot get access to pain
relieving drugs because doctors and pharmacists are seriously constrained
by regulatory barriers designed to prevent drug abuse. The problem
is even worse in non-white communities where one study showed only
25 percent of pharmacies maintain stocks of commonly prescribed
pain relievers.
An AGS panel chaired by Bruce A. Ferrell, MD,
argued today at the AGS 2001 Annual Scientific Meeting that these
problems, and publicity about street abuse of pain relievers such
as oxycontin, discourage patients and their families from accepting
these prescriptions even when they're desperately needed.
Diane Meier, MD, noted that aged or dying patients
fear addiction instead of concentrating on the more serious problem
of alleviation of pain and discomfort. "They're scared away
by the media reports on abuse, but the media should be focusing
on the problem of denial of pain relief, which impacts many thousands
more people."
The panel also noted that physicians must use
special costly triplicate prescription pads to meet Drug Enforcement
Agency (DEA) regulations in almost all states including California
and New York, and pharmacists would rather not stock the drugs for
fear of running afoul of DEA regulations.
Sean Morrison, MD, Director of Palliative Care
Research at Mount Sinai's Hertzberg Palliative Care Institute, also
cited a study that showed the impact is more pronounced for non-white
patients. The study found that only 25 percent of pharmacies in
predominantly non-white neighborhoods in New York City (those in
which less than 40 percent of residents were white) had adequate
supplies of medications commonly prescribed for severe pain, compared
with 72 percent of pharmacies in predominantly white neighborhoods
(those in which 80 to 100 percent of residents were white). The
study was conducted after Dr. Morrison and his colleagues found
that Black and Hispanic patients with serious life threatening diseases
could not fill their prescriptions.
Other barriers to filling prescriptions included
lack of health care coverage for these prescriptions for Medicare
patients and a $15 a month limitation on filling Medicaid patient
prescriptions.
Bruce Ferrell is associate professor of medicine
at the University of California at Los Angeles School of Medicine.
Diane Meier is Director of the Palliative Care Institute at the
Mount Sinai School of Medicine and Professor of Geriatrics and Internal
Medicine, and Sean Morrison is Director of Palliative Care Research
at Mount Sinai's Hertzberg Palliative Care Institute.
|